$24.7 Billion is the total value of VIKING GLOBAL INVESTORS LP's 91 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MA | New | MASTERCARD INCORPORATEDcl a | $640,957,000 | – | 1,793,488 | +100.0% | 2.59% | – |
| XP | New | XP INCcl a | $284,244,000 | – | 9,443,312 | +100.0% | 1.15% | – |
| OTIS | New | OTIS WORLDWIDE CORP | $272,262,000 | – | 3,538,164 | +100.0% | 1.10% | – |
| SHOP | New | SHOPIFY INCcl a | $151,226,000 | – | 223,721 | +100.0% | 0.61% | – |
| PGR | New | PROGRESSIVE CORP | $118,243,000 | – | 1,037,306 | +100.0% | 0.48% | – |
| PRGO | New | PERRIGO CO PLC | $97,046,000 | – | 2,525,266 | +100.0% | 0.39% | – |
| MET | New | METLIFE INC | $95,733,000 | – | 1,362,166 | +100.0% | 0.39% | – |
| New | AMYLYX PHARMACEUTICALS INC | $92,141,000 | – | 7,170,536 | +100.0% | 0.37% | – | |
| DG | New | DOLLAR GEN CORP NEW | $86,451,000 | – | 388,317 | +100.0% | 0.35% | – |
| INSP | New | INSPIRE MED SYS INC | $79,800,000 | – | 310,881 | +100.0% | 0.32% | – |
| ANTM | New | ANTHEM INC | $69,210,000 | – | 140,895 | +100.0% | 0.28% | – |
| BX | New | BLACKSTONE INC | $64,687,000 | – | 509,587 | +100.0% | 0.26% | – |
| BA | New | BOEING CO | $58,474,000 | – | 305,347 | +100.0% | 0.24% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $39,222,000 | – | 76,910 | +100.0% | 0.16% | – |
| UNM | New | UNUM GROUP | $35,847,000 | – | 1,137,645 | +100.0% | 0.14% | – |
| JPM | New | JPMORGAN CHASE & CO | $16,318,000 | – | 119,706 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 36 | Q3 2023 | 7.0% |
| AMAZON COM INC | 34 | Q3 2023 | 10.6% |
| META PLATFORMS INC | 34 | Q3 2023 | 10.4% |
| MICROSOFT CORP | 30 | Q3 2023 | 9.1% |
| THERMO FISHER SCIENTIFIC INC | 29 | Q3 2023 | 5.4% |
| NETFLIX INC | 26 | Q2 2023 | 6.0% |
| MASTERCARD INCORPORATED | 25 | Q3 2023 | 3.9% |
| ELEVANCE HEALTH INC | 24 | Q2 2023 | 10.2% |
| ALPHABET INC | 22 | Q2 2021 | 9.3% |
| UNITEDHEALTH GROUP INC | 22 | Q3 2023 | 5.3% |
View VIKING GLOBAL INVESTORS LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Celldex Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Coupa Software IncSold out | February 14, 2023 | 0 | 0.0% |
| FIGS, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Guardant Health, Inc. | February 14, 2023 | 4,107,644 | 4.0% |
| Orion Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| PROCEPT BioRobotics CorpSold out | February 14, 2023 | 0 | 0.0% |
| Frazier Lifesciences Acquisition CorpSold out | November 25, 2022 | 0 | 0.0% |
| Cazoo Group Ltd | November 10, 2022 | 60,000,000 | 7.3% |
| AbCellera Biologics Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-20 |
| SC 13G/A | 2024-03-20 |
| 4 | 2024-03-07 |
| 4 | 2024-03-07 |
| 4 | 2024-03-01 |
| 4 | 2024-03-01 |
| SC 13G/A | 2024-03-01 |
| 4 | 2024-02-28 |
| 4 | 2024-02-28 |
| SC 13G/A | 2024-02-28 |
View VIKING GLOBAL INVESTORS LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.